Green jackfruit flour ameliorates MASH and development of HCC via the AMPK and MAPK signaling pathways in experimental model systems

Green jackfruit flour ameliorates MASH and development of HCC via the AMPK and MAPK signaling pathways in experimental model systems

Abstract Metabolic dysfunction-associated steatotic liver disease (MASLD) is a serious public health concern. Given the paucity of approved therapeutic strategies for this lifestyle disorder, dietary interventions may prove effective. We evaluated the mechanisms of how green jackfruit flour (JF) ame...

Full description

Saved in:
Bibliographic Details
Main Authors: Diwakar Suresh, Bharathwaaj Gunaseelan, Akshatha N. Srinivas, Amith Bharadwaj, James Joseph, Megha, Thomas Varughese, Suchitha Satish, Deepak Suvarna, Prasanna K. Santhekadur, Saravana Babu Chidambaram, Ajay Duseja, Divya P. Kumar
Format: Article
Language:English
Published: Nature Portfolio 2025-04-01
Series:Scientific Reports
Subjects:
NAFLD
NASH
MASLD
Liver injury
Inflammation
Metabolic syndrome
Online Access:https://doi.org/10.1038/s41598-025-96944-1
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Abstract Metabolic dysfunction-associated steatotic liver disease (MASLD) is a serious public health concern. Given the paucity of approved therapeutic strategies for this lifestyle disorder, dietary interventions may prove effective. We evaluated the mechanisms of how green jackfruit flour (JF) ameliorates metabolic-dysfunction-associated steatohepatitis (MASH) and halts the progression to hepatocellular carcinoma (HCC). The study used murine models of MASH and MASH-HCC that closely mimic human MASLD. C57Bl/6 male mice were fed with chow or western diet with normal or sugar water for 12 weeks, then randomized to receive either 5 kcal% green jackfruit flour (JF) or an equal volume of placebo flour (PB). JF significantly reduced body weight, liver injury, and insulin resistance, and alleviated obesity, steatosis, inflammation, fibrosis, and tumor development in WDSW or WDSW/CCl4 mice compared to placebo. Furthermore, JF activated AMPK (AMP-activated protein kinase) and inhibited MAPK (mitogen-activated protein kinase) signaling pathways in MASH and MASH-HCC models, respectively. Sodium propionate treatment, the primary short-chain fatty acid entering the liver from JF’s soluble fiber microbial fermentation, further supported these mechanistic insights. Hence, our findings present strong evidence of JF’s therapeutic potential in attenuating MASH and MASH-HCC, warranting further investigation of JF’s efficacy as a dietary intervention in clinical trials.
ISSN:2045-2322

Similar Items